LAST PRICE - AT THE CLOSE
DRUG is DOWN -8% since the begininning of the year
DRUG is DOWN -0% BELOW 20 day SMA
DRUG is UP 35% ABOVE 200 day SMA
PROFITABLE: YES
EPS: $0.00695434
EARNINGS MOMENTUM: YES
1.02% INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00
 |
THE STOCK IS 58.1% AWAY FROM ALL-TIME HIGHS OF $79.02 |
 |
DRUG IS DOWN -8% SINCE THE BEGINNING OF THE YEAR |
 |
DRUG IS UP 2804% OVER THE PAST 12 MONTHS |
 |
DRUG IS DOWN -5% OVER THE PAST 1 MONTH |
 |
2% OF ALL DRUG INVESTORS ARE BETTING AGAINST DRUG |
 |
NUM INVESTORS SHORT DRUG HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|
 |
DRUG moved up 0 in the previous minute |
 |
DRUG is up 0.18 over the last hour |
 |
DRUG is up 10.2% over the last 5 days |
 |
DRUG is 9.2 above its 8 day SMA |
| $31.35 |   DAY |
$33.11 |
| $31.70 | PREVIOUS DAY |
$33.24 |
| $26.96 | WEEK |
$33.58 |
| $26.96 | MONTH |
$38.33 |
| $0.93 |  YEAR |
$79.02 |
DRUG is mentioned N/A less than normal on 
DRUG is mentioned N/A times in an average day on 
